SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024991
Filing Date
2022-11-14
Accepted
2022-11-14 16:11:21
Documents
74
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cue-20220930.htm   iXBRL 10-Q 2549885
2 EX-10.1 cue-ex10_1.htm EX-10.1 39304
3 EX-31.1 cue-ex31_1.htm EX-31.1 16796
4 EX-31.2 cue-ex31_2.htm EX-31.2 16896
5 EX-32.1 cue-ex32_1.htm EX-32.1 15941
6 GRAPHIC img76103294_0.jpg GRAPHIC 32011
7 GRAPHIC img76103294_1.jpg GRAPHIC 48480
8 GRAPHIC img76103294_2.jpg GRAPHIC 50454
  Complete submission text file 0000950170-22-024991.txt   9846530

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cue-20220930_pre.xml EX-101.PRE 396949
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cue-20220930_cal.xml EX-101.CAL 47810
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cue-20220930.xsd EX-101.SCH 63386
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cue-20220930_def.xml EX-101.DEF 247194
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cue-20220930_lab.xml EX-101.LAB 532233
68 EXTRACTED XBRL INSTANCE DOCUMENT cue-20220930_htm.xml XML 1703662
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 221385337
SIC: 2834 Pharmaceutical Preparations